Those doctors ruined my little girl's whole childhood.
For seven years, a child was treated for a disease she did not have, while the disease she did have quietly advanced. Faye Condon, a British girl now twelve years old, endured six rounds of chemotherapy, viral meningitis, and progressive physical decline before Great Ormond Street Hospital identified her true condition in August 2025: a rare, incurable genetic muscular dystrophy. Her story sits at the intersection of medicine's fallibility and a mother's unheeded certainty — a reminder that the cost of not listening is sometimes measured in a childhood.
- A five-year-old girl was placed on a chemotherapy regimen for an autoimmune disease she never had, setting in motion seven years of compounding harm.
- Her mother raised the possibility of muscular dystrophy repeatedly and was dismissed each time by doctors who treated parental instinct as an obstacle rather than a signal.
- Behind closed doors, hospital staff reportedly debated which department would fund further diagnostic testing, allowing financial friction to override a child's welfare.
- A second opinion at Derriford Hospital broke the impasse, leading to a referral to Great Ormond Street, where the correct diagnosis — Emery-Dreifuss muscular dystrophy type 2 — was finally confirmed.
- Faye is now wheelchair-dependent, requires a ventilator at night, and faces life-threatening cardiac complications; the window in which early management could have shaped her future has closed.
- Bristol NHS Foundation Trust has expressed sorrow but offered no accounting for how the misdiagnosis persisted for so long, leaving the family with a diagnosis, a deteriorating prognosis, and years they cannot reclaim.
Faye Condon was five years old when Bristol Children's Hospital diagnosed her with Juvenile Dermatomyositis and began chemotherapy. For years, she endured six rounds of the treatment — nausea so severe the family had to isolate, weakness that left her bedridden, and at one point viral meningitis triggered by a blood product that confined her to a darkened room for weeks. None of it was necessary. She did not have the disease they were treating.
Her mother, Christina Condon, sensed this early. Faye could not walk 180 metres to school without collapsing, complained of hip pain, and struggled to bear her own weight. Christina raised muscular dystrophy as a possibility — a genetic condition that runs in families — and was told categorically, each time, that it was not that. When she pushed for further testing, she encountered dismissal dressed as authority. Staff, it later emerged, were also arguing among themselves about which department would fund the diagnostic work.
The family reorganised their entire lives around a misdiagnosis. They deferred holidays, never adapted their home for a wheelchair, and held onto the belief that remission was coming. It never did. Faye lost the ability to walk. Schools turned her away as her needs grew too complex. The family's world narrowed to hospital appointments and treatment cycles.
Eventually, Christina sought a second opinion at Derriford Hospital. Those doctors listened, and referred Faye to Great Ormond Street in London. In August 2025, the true diagnosis arrived: Emery-Dreifuss muscular dystrophy type 2, a rare, progressive, incurable genetic condition affecting muscles and the heart. The clarity was devastating. Everything Faye had endured had been a response to the wrong disease, while the real one advanced without resistance.
Faye is now twelve, wheelchair-dependent, and deteriorating. She requires a ventilator at night and cannot sleep away from home. Her mother describes her as a ticking time bomb — cardiac complications could come without warning. Had the diagnosis been made at five, when Faye could still walk, the family might have travelled, made memories, prepared. Instead, her entire childhood was spent in hospitals. Christina holds gratitude toward the teams who finally got it right, and anger toward a system that took seven years to hear her. Bristol NHS Foundation Trust has expressed sorrow and promised to examine what happened. It has not yet explained how it happened.
Faye Condon was five years old when doctors at Bristol Children's Hospital told her parents she had Juvenile Dermatomyositis, a rare autoimmune disease in which the immune system attacks blood vessels. The diagnosis came with a treatment plan: chemotherapy. For the next several years, beginning in 2021, the girl endured six rounds of the grueling drug regimen. Her mother, Christina Condon, watched her daughter suffer through severe side effects—nausea so intense the family had to isolate from others, weakness that left Faye bedridden. At one point, a blood product administered by a doctor triggered viral meningitis, forcing the child into a darkened room for weeks. All of this was meant to save her life from an autoimmune disease she did not have.
Christina Condon began noticing inconsistencies early on. Faye struggled to walk even short distances—she couldn't make it 180 metres to school without collapsing. She complained of hip pain and had trouble bearing weight. The mother raised the possibility of muscular dystrophy with her daughter's doctors, a genetic disorder that runs in families and affects muscle strength. Each time, she was told no. The doctors were categorical: it was not muscular dystrophy. When Condon pushed for further testing, she encountered what she describes as indifference masked by medical authority. One doctor was dismissive, she recalls, throwing medications at the problem without conviction. Behind the scenes, hospital staff argued about which department would pay for the diagnostic tests Faye needed—the cost of investigation became a barrier to care.
For seven years, the family lived in a state of managed crisis. They kept Faye in and out of hospitals, postponed holidays, never invested in a wheelchair-accessible home because they were assured she would recover. They held onto the promise that chemotherapy would work, that the autoimmune disease would go into remission, that their daughter's childhood would eventually return to normal. It never did. Instead, Faye's condition worsened. She lost the ability to walk. Schools refused to enroll her as her needs became too complex. The family's life contracted around hospital appointments and treatment cycles.
In desperation, Christina Condon sought a second opinion at Derriford Hospital, her local facility. The doctors there listened. They referred Faye to Great Ormond Street Hospital in London, one of Britain's premier pediatric centers. In August 2025, after years of misdiagnosis and unnecessary treatment, Faye received her true diagnosis: Emery-Dreifuss muscular dystrophy type 2, a rare genetic condition with no cure. It is a degenerative disorder that primarily affects muscles in the upper arms, shoulders, and calves. It also attacks the heart. The revelation was both clarifying and devastating. Everything that had happened—the chemotherapy, the viral meningitis, the years of decline—had been a response to the wrong disease entirely.
The correct diagnosis came too late to change the trajectory of Faye's life. She is now twelve years old and wheelchair-dependent, her condition deteriorating rapidly. The muscular dystrophy is progressive, and her heart is compromised. She requires a ventilator at night and cannot sleep away from home like other children her age. Her mother describes her as a ticking time bomb—cardiac complications could strike without warning. Had the diagnosis been made when Faye was five and still able to walk, the family could have made different choices. They could have traveled, created memories, prepared for the future with accurate information. Instead, they spent her entire childhood in hospitals, chasing a treatment for a disease she didn't have, while the real disease advanced unchecked.
Christina Condon's anger is tempered by gratitude toward the doctors who finally got it right. She credits the team at Derriford Hospital with believing her, listening to her concerns as a parent, and pushing the system to find answers. Bristol NHS Foundation Trust, the organization that oversees Bristol Children's Hospital, issued a statement expressing sorrow for the family's experience and promising to understand what happened. The statement offered care and compassion but no explanation for how a child could undergo chemotherapy for seven years for a disease she did not have, or why a mother's repeated concerns about muscular dystrophy were dismissed as impossible. Faye Condon's childhood is gone. What remains is a diagnosis, a progressive disease, and the weight of years that cannot be recovered.
Notable Quotes
She was about seven for her first round of chemo and was so sick, it was awful. We couldn't be near anybody and she became really poorly, it was horrific to watch.— Christina Condon, Faye's mother, describing the side effects of chemotherapy
We have spent her entire childhood in and out of hospital, we haven't been on holidays and we don't have a house or car that is wheelchair accessible as we were told she was going to get better.— Christina Condon, on the impact of the misdiagnosis
The Hearth Conversation Another angle on the story
How does a hospital misdiagnose a child so completely that she undergoes chemotherapy for seven years?
The source material suggests a combination of anchoring bias and institutional inertia. Once the initial diagnosis was made, the doctors seemed locked into seeing Faye through that lens. When the mother raised muscular dystrophy, they dismissed it categorically rather than investigating.
The mother mentions financial arguments between departments about who would pay for tests. That's a striking detail.
It is. It suggests the misdiagnosis wasn't just clinical error—it was enabled by a system where the cost of investigation became a reason not to investigate. If testing is expensive and departments are fighting over budgets, the path of least resistance is to stick with the existing diagnosis.
What strikes you most about the timeline?
That Faye was five when this started and twelve when she got the correct diagnosis. Those are the years when a child is supposed to be building memories, running, playing, going to school normally. Instead, she was in hospitals. And by the time the diagnosis came, the disease had already progressed to the point where she's now wheelchair-bound and on a ventilator.
The mother says the doctors were "tainted" before they even saw Faye. What does that mean?
I think she means the doctor had already decided what disease Faye had—an autoimmune disease, a rheumatology case—and was filtering all new information through that assumption. When reality didn't fit the diagnosis, instead of questioning the diagnosis, they questioned the mother's observations.
Is there any indication the chemotherapy itself caused additional harm?
Yes. She contracted viral meningitis as a side effect of a blood product given during treatment. Chemotherapy is brutal on the body even when it's treating the right disease. When it's treating the wrong disease, it's just harm with no benefit.
What does the correct diagnosis mean for Faye's future?
Emery-Dreifuss muscular dystrophy is progressive and degenerative. There's no cure. The fact that it affects the heart means her life is now medically fragile. The mother said her daughter is a ticking time bomb—cardiac complications could be fatal. The childhood that was lost to misdiagnosis is now a childhood defined by a terminal condition.